Can a workplace campaign shade outdoor workers from skin cancer?

NCT ID NCT02824289

NEW Completed Prevention Sponsor: Klein Buendel, Inc. Source: ClinicalTrials.gov ↗

First seen Aug 18, 2026 · Last updated Aug 18, 2026

Summary

This trial tests a workplace program designed to encourage local government organizations to adopt sun protection policies for outdoor workers. The program provides education and resources to managers and employees, aiming to increase the use of sun-safe practices. Researchers will compare organizations that receive the program to those that do not, measuring whether formal policies are adopted and whether workers change their sun protection habits. The goal is to reduce skin cancer risk among people who work outdoors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Sun Safe Workplaces Program (a behavioral intervention promoting sun protection policies and education)
What this could lead to: If effective, this program could help outdoor workers adopt sun-safe habits and reduce their risk of skin cancer.
What could go wrong: The trial is early-stage and relies on voluntary policy adoption, so actual changes in sun protection practices may be limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SKIN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

skin neoplasm skin cancer prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SKIN CANCER

Contacts and locations

Locations

Kaiser Foundation Research Institute

Oakland, California, 94612-3466, United States
Klein Buendel, Inc.

Golden, Colorado, 80403, United States
University of Colorado Denver

Aurora, Colorado, 80045-0508, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.